// Biotech and Pharma Therapeutics New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar July 29, 2021 / Diabetes / FDA / Biologics The U.S. Food and Drug Administration (FDA) approved Viatris and Biocon Biologics’ Semglee (insulin glargine-yfgn...